Literature DB >> 6411730

NH2-terminal processing of Drosophila melanogaster actin. Sequential removal of two amino acids.

P A Rubenstein, D J Martin.   

Abstract

Class II actins, such as Drosophila and mammalian skeletal muscle actins, have genes that code for a Met-X-Asp NH2 terminus where X is usually cysteine. These actins have an Ac-Asp NH2 terminus so two amino acids must be removed. To determine the nature of this processing, we labeled Drosophila Schneider L-2 cells with [35S]methionine or cysteine, isolated the actin, and analyzed the NH2-terminal actin tryptic peptides and their thermolysin digestion products. After a 4-h labeling period, we detected completed actin polypeptide chains with either an unblocked Asp or an Ac-Asp NH2 terminus. No intermediate with an NH2-terminal Cys or Met could be demonstrated. If, however, Drosophila mRNA was translated in a mRNA-dependent rabbit reticulocyte lysate system, an additional 43-kDa actin intermediate was observed. On the basis of thermolysin digestion studies and experiments using mild acid hydrolysis of a labeled actin NH2-terminal tryptic peptide fragment, we identified this intermediate as having an Ac-Cys-Asp NH2 terminus. In a time-dependent fashion, Ac-Cys was removed generating actin with an exposed NH2-terminal Asp which was subsequently acetylated to produce the mature form of actin. The removal of Met and the acetylation of Cys may occur early in translation while the nascent polypeptide chain is still attached to the ribosome. Subsequent processing occurs following completion of the synthesis of the actin polypeptide. The removal of Ac-Cys from Drosophila actin is thus similar to removal of Ac-Met from the NH2 terminus of class I actins although in the case of the class II actins, it is the second amino acid that is removed as an acetylated species.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6411730

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

Review 1.  The N-end rule pathway: emerging functions and molecular principles of substrate recognition.

Authors:  Shashikanth M Sriram; Bo Yeon Kim; Yong Tae Kwon
Journal:  Nat Rev Mol Cell Biol       Date:  2011-10-21       Impact factor: 94.444

2.  NATure of actin amino-terminal acetylation.

Authors:  Peter A Rubenstein; Kuo-Kuang Wen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-04-09       Impact factor: 11.205

3.  Molecular mechanism of the E99K mutation in cardiac actin (ACTC Gene) that causes apical hypertrophy in man and mouse.

Authors:  Weihua Song; Emma Dyer; Daniel J Stuckey; O'Neal Copeland; Man-Ching Leung; Christopher Bayliss; Andrew Messer; Ross Wilkinson; Jordi Lopez Tremoleda; Michael D Schneider; Sian E Harding; Charles S Redwood; Kieran Clarke; Kristen Nowak; Lorenzo Monserrat; Dominic Wells; Steven B Marston
Journal:  J Biol Chem       Date:  2011-05-26       Impact factor: 5.157

4.  Characterization of the human Nalpha-terminal acetyltransferase B enzymatic complex.

Authors:  Amagoia Ametzazurra; Cristina Gázquez; Marta Lasa; Esther Larrea; Jesús Prieto; Rafael Aldabe
Journal:  BMC Proc       Date:  2009-08-04

5.  Cerebral microvascular smooth muscle in tissue culture.

Authors:  S A Moore; A R Strauch; E J Yoder; P A Rubenstein; M N Hart
Journal:  In Vitro       Date:  1984-06

6.  Actin's N-terminal acetyltransferase uncovered.

Authors:  Thomas Arnesen; Ronen Marmorstein; Roberto Dominguez
Journal:  Cytoskeleton (Hoboken)       Date:  2018-08-26

7.  Flightin, a novel myofibrillar protein of Drosophila stretch-activated muscles.

Authors:  J O Vigoreaux; J D Saide; K Valgeirsdottir; M L Pardue
Journal:  J Cell Biol       Date:  1993-05       Impact factor: 10.539

8.  NAA80 is actin's N-terminal acetyltransferase and regulates cytoskeleton assembly and cell motility.

Authors:  Adrian Drazic; Henriette Aksnes; Michaël Marie; Malgorzata Boczkowska; Sylvia Varland; Evy Timmerman; Håvard Foyn; Nina Glomnes; Grzegorz Rebowski; Francis Impens; Kris Gevaert; Roberto Dominguez; Thomas Arnesen
Journal:  Proc Natl Acad Sci U S A       Date:  2018-03-26       Impact factor: 11.205

9.  Isogenic Pairs of hiPSC-CMs with Hypertrophic Cardiomyopathy/LVNC-Associated ACTC1 E99K Mutation Unveil Differential Functional Deficits.

Authors:  James G W Smith; Thomas Owen; Jamie R Bhagwan; Diogo Mosqueira; Elizabeth Scott; Ingra Mannhardt; Asha Patel; Roberto Barriales-Villa; Lorenzo Monserrat; Arne Hansen; Thomas Eschenhagen; Sian E Harding; Steve Marston; Chris Denning
Journal:  Stem Cell Reports       Date:  2018-11-01       Impact factor: 7.765

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.